Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-17-065240

President and CEO acquired 12,500 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2017-12-12 Conversion +12,500 12,500 D
Derivatives
Watts Ryan J. President and CEO 2017-12-12 Conversion · Series B-1 Preferred Stock −12,500 0 D
Loading xslF345X03/doc4.xml…